Alembic Pharma received eight USFDA approvals in Q3FY24 EP News Bureau Jan 2, 2024 The company has received five final approvals and three tentative approvals
Zydus Cadila gets tentative US FDA nod for Osimertinib Tablets EP News Bureau Jun 3, 2021 Osimertinib is a kinase inhibitor used to treat lung cancer
AstraZeneca Pharma India gets DCGI approval for Osimertinib tablets EP News Bureau Mar 11, 2021 It is now approved as monotherapy for adjuvant treatment after complete tumour resection in patients with NSCLC